FDA takes first step in possible reversal of ban on some peptides The Washington Post FDA Peptide Update: Category 2 Removals Explained The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion